Revive Therapeutics Ltd (RVVTF)

[Gatorca]

The development of a useful therapeutic treatment for COVID-19 would be substantial. As a low-market cap, non-vaccine COVID-19 therapeutic company currently undergoing a Phase 3 trial, Revive executives believe the company has strong growth potential as its Bucillamine trial meets safety and efficacy endpoints.
Just wanted to repost the USA Today News for any new investors

https://www.usatoday.com/story/sponsor-story/imperium-group/2021/01/25/revive-therapeutics-phase-3-clinical-trial-covid-19-treatment/6672439002/